COL17A1 and breast carcinoma: Nevertheless, our approach led us to identify reduced COL17A1 mRNA levels as a strong independent prognostic marker in breast cancer development and this was not only sustained at the protein level, but it was also strongly associated with advanced stage, increased invasion, and postmenopausal status.